Computational vaccinology and epitope vaccine design by immunoinformatics

Acta Microbiologica et Immunologica Hungarica

Volumn 61, Issue 3, 2014, Pages 285-307

  Khalili, Saeed ^a,b,c,d   Jahangiri, Abolfazl ^a,b,c,d   Borna, Hojat ^a,b,c,d   Ahmadi Zanoos, Kobra ^a,b,c,d   Amani, Jafar ^a,b,c,d  

^a TARBIAT MODARES UNIVERSITY   (Iran)

^b BAQIYATALLAH UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c Chemical Injury Research Center   (Iran)

^d SHAHED UNIVERSITY   (Iran)

Author keywords

immunoinformatics; immunology; new vaccine design

Indexed keywords

ALLERGEN; EPITOPE; VACCINE;

ALLERGY; ARTICLE; B LYMPHOCYTE; BIOINFORMATICS; COMPUTER MODEL; DATA BASE; EPITOPE MAPPING; GENOMICS; HUMAN; IMMUNE SYSTEM; IMMUNOLOGICAL PROCEDURES; MEDICAL INFORMATICS; MEDICAL RESEARCH; MOLECULAR EVOLUTION; T LYMPHOCYTE; VACCINE PRODUCTION; ANIMAL; BIOLOGY; DRUG DESIGN; EVALUATION STUDY; GENETIC DATABASE; GENETICS; IMMUNOLOGY; PROCEDURES;

ANIMALS; COMPUTATIONAL BIOLOGY; DATABASES, GENETIC; DRUG DESIGN; EPITOPES; HUMANS; VACCINES;

EID: 84907500966     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.61.2014.3.4     Document Type: Article

References (132)

1. Ortutay, C., Vihinen, M.: Immunome Knowledge Base (IKB): An integrated service for immunome research. BMC immunology 10, 3 (2009).
2. Sette, A., Fleri, W., Peters, B., Sathiamurthy, M., Bui, H.H., Wilson, S.: A roadmap for the immunomics of category AC pathogens. Immunity 22, 155-161 (2005).
3. De Groot, A.S.: Immunomics: Discovering new targets for vaccines and therapeutics. Drug Discovery Today 11, 203-209 (2006).
4. Grainger, D.J.: Immunomics: Principles and practice. IRTL 2, 1-6 (2004).
5. Bock, G., Goode, J.: Immunoinformatics: Bioinformatic Strategies for Better Understanding of Immune Function, Edition. John Wiley & Sons Ltd, Chichester, UK, 2003.
6. Tong, J.C., Ren, E.C.: Immunoinformatics: Current trends and future directions. Drug Discovery Today 14, 684-689 (2009).
7. Ross, R.: An application of the theory of probabilities to the study of a priori pathometry. Part I. Proceedings of the Royal Society of London. Series A 92, 204 (1916).
8. Gardy, J.L., Lynn, D.J., Brinkman, F.S.L., Hancock, R.E.W.: Enabling a systems biology approach to immunology: focus on innate immunity. Trends in Immunology 30, 249-262 (2009).
9. Tomar, N., De, R.K.: Immunoinformatics: An integrated scenario. Immunology 131, 153-168 (2010).
10. Davies, M.N., Flower, D.R.: Harnessing bioinformatics to discover new vaccines. Drug Discovery Today 12, 389-395 (2007).
11. Brusic, V., Zeleznikow, J., Petrovsky, N.: Molecular immunology databases and data repositories. Journal of Immunological Methods 238, 17-28 (2000).
12. Glynne, J., Watson, R.: The immune system and gene expression microarrays - New answers to old questions. The Journal of Pathology 195, 20-30 (2001).
13. Brusic, V., Zeleznikow, J.: Computational binding assays of antigenic peptides. Letters in Peptide Science 6, 313-324 (1999).
14. Bernaschi, M., Castiglione, F.: Selection of escape mutants from immune recognition during HIV infection. Immunology and Cell Biology 80, 307-313 (2002).
15. Gendel, S.M.: Sequence analysis for assessing potential allergenicity. Annals of the New York Academy of Sciences 964, 87-98 (2002).
16. Ruiz, M., Lefranc, M.P.: IMGT gene identification and Colliers de Perles of human immunoglobulins with known 3D structures. Immunogenetics 53, 857-883 (2001).
17. Eckmann, L.: Sensor molecules in intestinal innate immunity against bacterial infections. Current Opinion in Gastroenterology 22, 95-101 (2006).
18. Korber, B., LaBute, M., Yusim, K.: Immunoinformatics comes of age. PLoS Computational Biology 2, e71 (2006).
19. Hanada, K., Yewdell, J.W., Yang, J.C.: Immune recognition of a human renal cancer antigen through post-translational protein splicing. Nature 427, 252-256 (2004).
20. Janeway, C., Travers, P., Walport, M., Shlomchick, M.: Immunobiology, 2005. Garland Science, New York, USA and London, UK.
21. Rudolph, M.G., Stanfield, R.L., Wilson, I.A.: How TCRs bind MHCs, peptides, and coreceptors. Annu Rev Immunol 24, 419-466 (2006).
22. Maenaka, K., Jones, E.Y.: MHC superfamily structure and the immune system. Current Opinion in Structural Biology 9, 745-753 (1999).
23. Messaoudi, I., LeMaoult, J., Metzner, B.M., Miley, M.J., Fremont, D.H., Nikolich-Zugich, J.: Functional evidence that conserved TCR CDR 3 loop docking governs the cross-recognition of closely related peptide: Class I complexes. The Journal of Immunology 167, 836 (2001).
24. Hammond, S.A., Obah, E., Stanhope, P., Monell, C.R., Strand, M., Robbins, F., Bias, W.B., Karr, R.W., Koenig, S., Siliciano, R.: Characterization of a conserved T cell epitope in HIV-1 gp41 recognized by vaccine-induced human cytolytic T cells. The Journal of Immunology 146, 1470 (1991).
25. Kagi, D., Ledermann, B., Burki, K., Seiler, P., Odermatt, B., Olsen, K., Podack, E., Zinkernagel, R., Hengartner, H.: Cytotoxicity mediated by T cells and natural killer cells is greatly impaired in perforin-deficient mice. Nature 369, 31-36 (1994).
26. Craiu, A., Akopian, T., Goldberg, A., Rock, K.L.: Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proceedings of the National Academy of Sciences 94, 10850-10855 (1997).
27. Pamer, E., Cresswell, P.: Mechanisms of MHC class I-restricted antigen processing. Annual Review of Immunology 16, 323-358 (1998).
28. Matsumura, M., Fremont, D.H., Peterson, P.A., Wilson, I.A.: Emerging principles for the recognition of peptide antigens by MHC class I molecules. Science 257, 927-934 (1992).
29. Abele, R., Tampé, R.: Function of the transport complex TAP in cellular immune recognition. Biochimica et Biophysica Acta (BBA)-Biomembranes 1461, 405-419 (1999).
30. Hammond, S.A., Johnson, R.P., Kalams, S.A., Walker, B.D., Takiguchi, M., Safrit, J.T., Koup, R.A., Siliciano, R.F.: An epitope-selective, transporter associated with antigen presentation (TAP)-1/2-independent pathway and a more general TAP-1/2-dependent antigen-processing pathway allow recognition of the HIV-1 envelope glycoprotein by CD8+ CTL. The Journal of Immunology 154, 6140-6156 (1995).
31. Peters, B., Sidney, J., Bourne, P., Bui, H.H., Buus, S., Doh, G., Fleri, W., Kronenberg, M., Kubo, R., Lund, O.: The immune epitope database and analysis resource: from vision to blueprint. PLoS biology 3, e91 (2005).
32. Martin, A.C.R.: Accessing the Kabat antibody sequence database by computer. Proteins: Structure, Function, and Bioinformatics 25, 130-133 (1996).
33. Toseland, C., Clayton, D., McSparron, H., Hemsley, S., Blythe, M., Paine, K., Doytchinova, I., Guan, P., Hattotuwagama, C., Flower, D.: AntiJen: A quantitative immunology database integrating functional, thermodynamic, kinetic, biophysical, and cellular data. Immunome Res 1, 4 (2005).
34. Saha, S., Bhasin, M., Raghava, G.: Bcipep: a database of B-cell epitopes. BMC Genomics 6, 79 (2005).
35. Huang, J., Honda, W.: CED: A conformational epitope database. BMC Immunology 7, 7 (2006).
36. Schlessinger, A., Ofran, Y., Yachdav, G., Rost, B.: Epitome: Database of structure-inferred antigenic epitopes. Nucleic Acids Research 34, D777 (2006).
37. Vita, R., Zarebski, L., Greenbaum, J.A., Emami, H., Hoof, I., Salimi, N., Damle, R., Sette, A., Peters, B.: The immune epitope database 2.0. Nucleic Acids Res 38, D854-D862 (2010).
38. Lefranc, M.P., Giudicelli, V., Ginestoux, C., Jabado-Michaloud, J., Folch, G., Bellahcene, F., Wu, Y., Gemrot, E., Brochet, X., Lane, J.: IMGT®, the international ImMunoGeneTics information system®. Nucleic Acids Research 37, D1006 (2009).
39. Singh, M.K., Srivastava, S., Raghava, G., Varshney, G.C.: HaptenDB: A comprehensive database of haptens, carrier proteins and anti-hapten antibodies. Bioinformatics 22, 253 (2006).
40. Yusim, K., Korber, B., Brander, C., Haynes, B., Koup, R., Moore, J., Walker, B., Watkins, D.: HIV Molecular Immunology 2009. Los Alamos National Laboratory, Theoretical Biology and Biophysics, Los Alamos, NM, 2009.
41. Yusim, K., Richardson, R., Tao, N., Dalwani, A., Agrawal, A., Szinger, J., Funkhouser, R., Korber, B., Kuiken, C.: Los Alamos hepatitis C immunology database. Applied Bioinformatics 4, 217-225 (2005).
42. Panchenko, A.R., Madej, T.: Analysis of protein homology by assessing the (dis)similarity in protein loop regions. Proteins 57, 539-547 (2004).
43. Allcorn, L.C., Martin, A.C.R.: SACS - self-maintaining database of antibody crystal structure information. Bioinformatics 18, 175 (2002).
44. Saha, S., Raghava, G.: Prediction of continuous B cell epitopes in an antigen using recurrent neural network. Proteins: Structure, Function, and Bioinformatics 65, 40-48 (2006).
45. Ghate, A., Bhagwat, B., Bhosle, S., Gadepalli, S., Kulkarni-Kale, U.: Characterization of antibody-binding sites on proteins: Development of a knowledge base and its applications in improving epitope prediction. Protein and Peptide Letters 14, 531-535 (2007).
46. Saha, S., Raghava, G.: BcePred: Prediction of continuous B-cell epitopes in antigenic sequences using physico-chemical properties. Artificial Immune Systems, Lecture Notes in Computer Science 3239, 197-201 (2004).
47. Larsen, J.E.P., Lund, O., Nielsen, M.: Improved method for predicting linear B-cell epitopes. Immunome Research 2, 2 (2006).
48. Odorico, M., Pellequer, J.-L.: BEPITOPE: Predicting the location of continuous epitopes and patterns in proteins. Journal of Molecular Recognition 16, 20-22 (2003).
49. Sweredoski, M.J., Baldi, P.: COBEpro: A novel system for predicting continuous B-cell epitopes. Protein Engineering Design and Selection 22, 113-120 (2009).
50. Schreiber, A., Humbert, M., Benz, A., Dietrich, U.: 3D-Epitope-Explorer (3DEX): Localization of conformational epitopes within three-dimensional structures of proteins. Journal of Computational Chemistry 26, 879-887 (2005).
51. Haste Andersen, P., Nielsen, M., Lund, O.: Prediction of residues in discontinuous B cell epitopes using protein 3D structures. Protein Science 15, 2558-2567 (2006).
52. Moreau, V., Granier, C., Villard, S., Laune, D., Molina, F.: Discontinuous epitope prediction based on mimotope analysis. Bioinformatics 22, 1088-1095 (2006).
53. Huang, J., Gutteridge, A., Honda, W., Kanehisa, M.: MIMOX: A web tool for phage display based epitope mapping. BMC Bioinformatics 7, 451 (2006).
54. Mayrose, I., Penn, O., Erez, E., Rubinstein, N.D., Shlomi, T., Freund, N.T., Bublil, E.M., Ruppin, E., Sharan, R., Gershoni, J.M., Martz, E., Pupko, T.: Pepitope: Epitope mapping from affinity-selected peptides. Bioinformatics (Oxford, England) 23, 3244-3246 (2007).
55. Gonzalez-Galarza, F.F., Christmas, S., Middleton, D., Jones, A.R.: Allele frequency net: A database and online repository for immune gene frequencies in worldwide populations. Nucleic Acids Research 39, D913 (2011).
56. Wheeler, D.L., Church, D.M., Lash, A.E., Leipe, D.D., Madden, T.L., Pontius, J.U., Schuler, G.D., Schriml, L.M., Tatusova, T.A., Wagner, L., Rapp, B.A.: Database resources of the National Center for Biotechnology Information: 2002 update. Nucleic Acids Res 30, 13-16 (2002).
57. Feldhahn, M., Dönnes, P., Thiel, P., Kohlbacher, O.: FRED - A framework for T-cell epitope detection. Bioinformatics 25, 2758-2759 (2009).
58. McSparron, H., Blythe, M.J., Zygouri, C., Doytchinova, I.A., Flower, D.R.: JenPep: A novel computational information resource for immunobiology and vaccinology. Journal of Chemical Information and Computer Sciences 43, 1276-1287 (2003).
59. Bhasin, M., Singh, H., Raghava, G.: MHCBN: A comprehensive database of MHC binding and non-binding peptides. Bioinformatics 19, 665 (2003).
60. Horton, R., Gibson, R., Coggill, P., Miretti, M., Allcock, R., Almeida, J., Forbes, S., Gilbert, J., Halls, K., Harrow, J., Hart, E., Howe, K., Jackson, D., Palmer, S., Roberts, A., Sims, S., Stewart, C., Traherne, J., Trevanion, S., Wilming, L., Rogers, J., de Jong, P., Elliott, J., Sawcer, S., Todd, J., Trowsdale, J., Beck, S.: Variation analysis and gene annotation of eight MHC haplotypes: The MHC Haplotype Project. Immunogenetics 60, 1-18 (2008).
61. Brusic, V., Rudy, G., Harrison, L.C.: MHCPEP, a database of MHC-binding peptides: Update 1997. Nucleic Acids Research 26, 368-371 (1998).
62. Rammensee, H.G., Bachmann, J., Emmerich, N.P.N., Bachor, O.A., Stevanovi, S.: SYFPEITHI: Database for MHC ligands and peptide motifs. Immunogenetics 50, 213-219 (1999).
63. Parker, K.C., Bednarek, M.A., Coligan, J.E.: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. The Journal of Immunology 152, 163 (1994).
64. Ponomarenko, J., Bui, H.H., Li, W., Fusseder, N., Bourne, P.E., Sette, A., Peters, B.: ElliPro: A new structure-based tool for the prediction of antibody epitopes. BMC Bioinformatics 9, 514 (2008).
65. Guan, P., Doytchinova, I.A., Zygouri, C., Flower, D.R.: MHCPred: A server for quantitative prediction of peptide-MHC binding. Nucleic acids research 31, 3621 (2003).
66. Feldhahn, M., Thiel, P., Schuler, M.M., Hillen, N., Stevanovi, S., Rammensee, H.G., Kohlbacher, O.: EpiToolKit - a web server for computational immunomics. Nucleic Acids Research 36, W519 (2008).
67. Sidney, J., Sette, A., Berzofsky, J.A.: Anne S. De Groot, and Hakima Sbai Brown University, Providence, Rhode Island, USA. William Martin EpiVax, Inc., Providence, Rhode Island, USA. New Generation Vaccines 344 (2004).
68. Bhasin, M., Raghava, G.P.S.: Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22, 3195-3204 (2004).
69. Lada, O., Gervais, A., Branger, M., Peytavin, G., Roquebert, B., Collin, G., Fraqueiro, G., Moucari, R., Hamet, G., Martinot-Peignoux, M., Matheron, S., Marcellin, P.: Long-term outcome of primary non-responders to tenofovir therapy in HIV/HBV-co-infected patients: Impact of HBV genotype G. Liver Int 32, 93-101 (2012).
70. Singh, H., Raghava, G.: ProPred1: Prediction of promiscuous MHC Class-I binding sites. Bioinformatics 19, 1009 (2003).
71. Bhasin, M., Raghava, G.P.: Prediction of promiscuous and high-affinity mutated MHC binders. Hybrid Hybridomics 22, 229-234 (2003).
72. Nielsen, M., Lundegaard, C., Lund, O., Keómir, C.: The role of the proteasome in generating cytotoxic T-cell epitopes: Insights obtained from improved predictions of proteasomal cleavage. Immunogenetics 57, 33-41 (2005).
73. Larsen, M., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., Nielsen, M.: Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8, 424 (2007).
74. Nussbaum, A.K., Kuttler, C., Hadeler, K.P., Rammensee, H.G., Schild, H.: PAProC: A prediction algorithm for proteasomal cleavages available on the WWW. Immunogenetics 53, 87-94 (2001).
75. Bhasin, M., Raghava, G.: P cleavage: An SVM based method for prediction of constitutive proteasome and immunoproteasome cleavage sites in antigenic sequences. Nucleic Acids Research 33, W202 (2005).
76. Singh, H., Raghava, G.: ProPred: Prediction of HLA-DR binding sites. Bioinformatics 17, 1236 (2001).
77. Schuler, M., Nastke, M., Stevanovik, S.: SYFPEITHI: Database for searching and T-cell epitope prediction. Methods in Molecular Biology (Clifton, NJ) 409, 75 (2007).
78. Bhasin, M., Raghava, G.: Analysis and prediction of affinity of TAP binding peptides using cascade SVM. Protein Science 13, 596-607 (2004).
79. Parker, K.C., Bednarek, M.A., Coligan, J.E.: Scheme for ranking potential HLA-A2 binding peptides based on independent binding of individual peptide side-chains. The Journal of Immunology 152, 163-175 (1994).
80. Schönbach, C., Ranganathan, S., Brusic, V.: Immunoinformatics, Edition. Springer, New York, USA, 2008, pp. 19-49.
81. Niestijl Jansen, J.J., Kardinaal, A.F.M., Huijbers, G., Vlieg-Boerstra, B.J., Martens, B.P.M., Ockhuizen, T.: Prevalence of food allergy and intolerance in the adult Dutch population 1. Journal of Allergy and Clinical Immunology 93, 446-456 (1994).
82. Malone, D.C., Lawson, K.A., Smith, D.H., Michael Arrighi, H.: A cost of illness study of allergic rhinitis in the United States. Journal of Allergy and Clinical Immunology 99, 22-27 (1997).
83. Kanny, G., Moneret-Vautrin, D.A., Flabbee, J., Beaudouin, E., Morisset, M., Thevenin, F.: Population study of food allergy in France. Journal of Allergy and Clinical Immunology 108, 133-140 (2001).
84. Larche, M.: Specific immunotherapy. British Medical Bulletin 56, 1019 (2000).
85. Li, K.B., Issac, P., Krishnan, A.: Predicting allergenic proteins using wavelet transform. Bioinformatics 20, 2572 (2004).
86. Tong, J., Tammi, M.: Methods and protocols for the assessment of protein allergenicity and cross-reactivity. Frontiers in Bioscience: A Journal and Virtual Library 13, 4882 (2008).
87. Saha, S., Raghava, G.: AlgPred: Prediction of allergenic proteins and mapping of IgE epitopes. Nucleic Acids Research 34, W202 (2006).
88. Kim, C., Kwon, S., Lee, G., Lee, H., Choi, J., Kim, Y., Hahn, J.: A database for allergenic proteins and tools for allergenicity prediction. Bioinformation 3, 344 (2009).
89. Mari, A., Mari, V., Ronconi, A.: Allergome - A database of allergenic molecules: Structure and data implementations of a web-based resource. Journal of Allergy and Clinical Immunology 115, S87 (2005).
90. Fiers, M.W.E.J., Kleter, G.A., Nijland, H., Peijnenburg, A.A.C.M., Nap, J.P., Van Ham, R.C.H.J.: Allermatch, a webtool for the prediction of potential allergenicity according to current FAO/WHO Codex alimentarius guidelines. BMC Bioinformatics 5, 133 (2004).
91. Miyasaka, A., Suzuki, K.: [The clinical features of HBV asymptomatic carrier, and management]. Nihon Rinsho 69(Suppl 4), 434-439 (2011).
92. Imazeki, F., Wu, S., Arai, M., Kanda, T., Yokosuka, O.: [HBeAg and HBV DNA in chronic hepatitis B]. Nihon Rinsho 69(Suppl 4), 428-433 (2011).
93. Ogata, N., Funada, H., Aoyagi, Y.: [Indications and efficacy of hepatitis B vaccines (HB vaccines) and hepatitis B immune globulin (HBIG): Current situations and problems of hepatitis B virus (HBV) infection-preventing strategies in Japan]. Nihon Rinsho 69(Suppl 4), 408-416 (2011).
94. Barrio, A.M., Soeria-Atmadja, D., Nistér, A., Gustafsson, M.G., Hammerling, U., Bongcam-Rudloff, E.: EVALLER: A web server for in silico assessment of potential protein allergenicity. Nucleic Acids Research 35, W694 (2007).
95. Okuse, C., Yotsuyanagi, H.: [Protection from HBV infection in medical institution]. Nihon Rinsho 69(Suppl 4), 402-407 (2011).
96. Ivanciuc, O., Schein, C.H., Braun, W.: SDAP: Database and computational tools for allergenic proteins. Nucleic Acids Research 31, 359 (2003).
97. Ortutay, C., Siermala, M., Vihinen, M.: ImmTree: Database of evolutionary relationships of genes and proteins in the human immune system. Immunome Research 3, 4 (2007).
98. Rannikko, K., Ortutay, C., Vihinen, M.: Immunity genes and their orthologs: A multi-species database. International immunology 19, 1361 (2007).
99. Jahangiri, A., Rasooli, I., Gargari, S.L.M., Owlia, P., Rahbar, M.R., Amani, J., Khalili, S.: An in silico DNA vaccine against Listeria monocytogenes. Vaccine 29, 6948-6958 (2011).
100. Jahangiri, A., Rasooli, I., Reza Rahbar, M., Khalili, S., Amani, J., Ahmadi Zanoos, K.: Precise detection of L. monocytogenes hitting its highly conserved region possessing several specific antibody binding sites. Journal of Theoretical Biology 305, 15-23 (2012).
101. Rahbar, M.R., Rasooli, I., Gargari, S.L., Sandstrom, G., Amani, J., Fattahian, Y., Jahangiri, A., Jalali, M.: A potential in silico antibody-antigen based diagnostic test for precise identification of Acinetobacter baumannii. J Theor Biol 294, 29-39 (2012).
102. Toobak, H., Rasooli, I., Talei, D., Jahangiri, A., Owlia, P., Darvish Alipour Astaneh, S.: Immune response variations to Salmonella enterica serovar Typhi recombinant porin proteins in mice. Biologicals 41, 224-230 (2013).
103. Amani, J., Mousavi, S.L., Rafati, S., Salmanian, A.H.: In silico analysis of chimeric espA, eae and tir fragments of Escherichia coli O 157: H 7 for oral immunogenic applications. Theoretical Biology and Medical Modelling 6, 28 (2009).
104. Rahbar, M.R., Rasooli, I., Mousavi Gargari, S.L., Amani, J., Fattahian, Y.: In silico analysis of antibody triggering biofilm associated protein in Acinetobacter baumannii. Journal of Theoretical Biology 266, 275-290 (2010).
105. Amani, J., Mousavi, S.L., Rafati, S., Salmanian, A.H.: Immunogenicity of a plant-derived edible chimeric EspA, Intimin and Tir of Escherichia coli O157:H7 in mice. Plant Science 180, 620-627 (2011).
106. Altunöz, M. E., Şenateş, E., Yeşil, A., Çalhan, T., Övünç, A.O.K.: Patients with inflammatory bowel disease have a lower response rate to HBV vaccination compared to controls. Digestive Diseases and Sciences 57, 1039-1044 (2012).
107. De Groot, A.S., Sbai, H., Saint Aubin, C., McMurry, J., Martin, W.: Immuno-informatics: Mining genomes for vaccine components. Immunology and Cell Biology 80, 255-269 (2002).
108. Doytchinova, I.A., Flower, D.R.: VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinformatics 8, 4 (2007).
109. Harish, N., Gupta, R., Agarwal, P., Scaria, V., Pillai, B.: DyNAVacS: An integrative tool for optimized DNA vaccine design. Nucleic Acids Research 34, W264 (2006).
110. Vivona, S., Bernante, F., Filippini, F.: NERVE: New enhanced reverse vaccinology environment. BMC Biotechnology 6, 35 (2006).
111. Xiang, Z., Todd, T., Ku, K.P., Kovacic, B.L., Larson, C.B., Chen, F., Hodges, A.P., Tian, Y., Olenzek, E.A., Zhao, B.: VIOLIN: Vaccine investigation and online information network. Nucleic Acids Research 36, D923 (2008).
112. Xiang, Z., He, Y.: Vaxign: A web-based vaccine target design program for reverse vaccinology. Procedia in Vaccinology 1, 23-29 (2009).
113. Yewdell, J.W., Bennink, J.R.: Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses 1. Annual Review of Immunology 17, 51-88 (1999).
114. Paz, P., Brouwenstijn, N., Perry, R., Shastri, N.: Discrete proteolytic intermediates in the MHC class I antigen processing pathway and MHC I-dependent peptide trimming in the ER. Immunity 11, 241-251 (1999).
115. Craiu, A., Akopian, T., Goldberg, A., Rock, K.L.: Two distinct proteolytic processes in the generation of a major histocompatibility complex class I-presented peptide. Proc Natl Acad Sci U S A 94, 10850-10855 (1997).
116. Altuvia, Y., Margalit, H.: Sequence signals for generation of antigenic peptides by the proteasome: Implications for proteasomal cleavage mechanism. J Mol Biol 295, 879-890 (2000).
117. Mo, X., Cascio, P., Lemerise, K., Goldberg, A.L., Rock, K.: Distinct proteolytic processes generate the C and N termini of MHC class I-binding peptides. The Journal of Immunology 163, 5851-5859 (1999).
118. Stoltze, L., Dick, T.P., Deeg, M., Pommerl, B., Rammensee, H.G., Schild, H.: Generation of the vesicular stomatitis virus nucleoprotein cytotoxic T lymphocyte epitope requires proteasome-dependent and -independent proteolytic activities. Eur J Immunol 28, 4029-4036 (1998).
119. Juncker, A.S., Larsen, M.V., Weinhold, N., Nielsen, M., Brunak, S., Lund, O.: Systematic characterisation of cellular localisation and expression profiles of proteins containing MHC ligands. PLoS One 4, (2009).
120. Lévy, F., Burri, L., Morel, S., Peitrequin, A.L., Lévy, N., Bachi, A., Hellman, U., Van den Eynde, B.J., Servis, C.: The final N-terminal trimming of a subaminoterminal proline-containing HLA class I-restricted antigenic peptide in the cytosol is mediated by two peptidases. The Journal of Immunology 169, 4161 (2002).
121. Ritz, U., Seliger, B.: The transporter associated with antigen processing (TAP): Structural integrity, expression, function, and its clinical relevance. Mol Med 7, 149-158 (2001).
122. Koch, J., Guntrum, R., Heintke, S., Kyritsis, C., Tampé, R.: Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP). Journal of Biological Chemistry 279, 10142-10147 (2004).
123. van Endert, P.M., Tampe, R., Meyer, T.H., Tisch, R., Bach, J.F., McDevitt, H.O.: A sequential model for peptide binding and transport by the transporters associated with antigen processing. Immunity 1, 491-500 (1994).
124. Schatz, M.M., Peters, B., Akkad, N., Ullrich, N., Martinez, A.N., Carroll, O., Bulik, S., Rammensee, H.G., van Endert, P., Holzhütter, H.G.: Characterizing the N-terminal processing motif of MHC class I ligands. The Journal of Immunology 180, 3210-3217 (2008).
125. Stranzl, T., Larsen, M.V., Lundegaard, C., Nielsen, M.: NetCTLpan: Pan-specific MHC class I pathway epitope predictions. Immunogenetics 62, 357-368 (2010).
126. Larsen, M.V., Lundegaard, C., Lamberth, K., Buus, S., Lund, O., Nielsen, M.: Large-scale validation of methods for cytotoxic T-lymphocyte epitope prediction. BMC Bioinformatics 8, 424 (2007).
127. Bhasin, M., Raghava, G.P.: Prediction of CTL epitopes using QM, SVM and ANN techniques. Vaccine 22, 3195-3204 (2004).
128. Donnes, P., Kohlbacher, O.: Integrated modeling of the major events in the MHC class I antigen processing pathway. Protein Sci 14, 2132-2140 (2005).
129. Doytchinova, I.A., Guan, P., Flower, D.R.: EpiJen: A server for multistep T cell epitope prediction. BMC Bioinformatics 7, 131 (2006).
130. De Groot, A.S., Rappuoli, R.: Genome-derived vaccines. Expert Review of Vaccines 3, 59 (2004).
131. Kalita, J., Chandrashekar, K., Hans, R., Selvam, P.: Computational modelling and simulation of the immune system. International Journal of Bioinformatics Research and Applications 2, 63-88 (2006).
132. Castiglione, F., Liso, A.: The role of computational models of the immune system in designing vaccination strategies. Immunopharmacology and Immunotoxicology 27, 417-432 (2005).